Equities

Brainsway Ltd

Brainsway Ltd

Actions
Health CareMedical Equipment and Services
  • Price (ILa)1,096.00
  • Today's Change9.00 / 0.83%
  • Shares traded30.95k
  • 1 Year change+284.56%
  • Beta1.6019
Data delayed at least 20 minutes, as of May 06 2024 15:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

  • Revenue in ILS (TTM)117.77m
  • Net income in ILS-15.55m
  • Incorporated2006
  • Employees134.00
  • Location
    Brainsway Ltd19 Hartum StBynet Building, Har HotzvimJERUSALEM 9777518IsraelISR
  • Phone+972 25824030
  • Fax+972 25812517
  • Websitehttps://www.brainsway.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Epitomee Medical Ltd37.05m-21.05m91.06m42.00--0.7062--2.46-0.7112-0.71121.254.330.2095--35.21882,190.50-11.90---12.44-------56.82------0.1021------63.08------
Nissan Medical Industries Ltd.733.91m5.65m127.99m395.0023.840.55972.550.17440.59110.591179.1725.181.025.406.921,858,010.002.644.125.017.7118.5018.762.594.320.63751.830.3585--7.202.20115.67-25.79-3.21--
Pulsenmore Ltd6.19m-58.57m167.52m76.00--1.27--27.07-1.14-1.140.12082.640.02970.21022.2681,421.05-28.14---30.33--35.57---946.46--10.00-19.480.1734---42.78---164.78------
Bonus Biogroup Ltd0.00-28.53m193.88m58.00--6.62-----0.064-0.0640.000.02510.00----0.00-47.75-76.10-53.85-97.19------------0.2758------26.29--19.30--
Elron Ventures Ltd17.52m-30.29m273.67m8.00--0.5656--15.62-0.6079-0.60790.35049.170.0287--0.3217---6.671.60-7.642.0573.33---232.4770.60---0.10050.067227.98-25.8927.74-111.76---44.01--
Brainsway Ltd117.77m-15.55m358.56m134.00--2.33--3.04-0.4698-0.46983.584.630.49882.207.37---6.59-15.50-7.66-18.3573.8675.91-13.20-29.695.30------16.9614.1568.56--3.89--
InterCure Ltd414.79m20.90m523.17m350.0025.441.0321.881.260.45120.45129.0511.160.50742.334.001,185,120.002.13-0.20112.99-0.270536.04--4.19-0.54021.241.660.2358--76.93--855.22------
Sofwave Medical Ltd-100.00bn-100.00bn583.12m----6.04----------2.81------------------------2.12--0.048--41.22--57.61------
Ilex Medical Ltd930.89m50.89m718.28m223.0014.111.157.280.77164.554.5583.1955.730.97214.583.484,174,395.005.3113.847.2120.8924.9131.085.4712.171.8918.830.071929.516.699.14-50.171.6116.32-11.34
Data as of May 06 2024. Currency figures normalised to Brainsway Ltd's reporting currency: Israeli Shekel ILS

Institutional shareholders

14.16%Per cent of shares held by top holders
HolderShares% Held
Phoenix Provident Fund Ltd.as of 18 Mar 20243.77m11.33%
Meitav Mutual Funds Ltd.as of 29 Feb 2024476.05k1.43%
Psagot Mutual Funds Ltd.as of 29 Feb 2024122.56k0.37%
KSM Mutual Funds Ltd.as of 29 Feb 2024100.75k0.30%
Analyst IMS Mutual Funds Management (1986) Ltd.as of 29 Feb 202476.33k0.23%
Migdal Mutual Funds Ltd.as of 29 Feb 202447.63k0.14%
IBI Mutual Funds Management (1978) Ltd.as of 29 Feb 202438.79k0.12%
Bessemer Investment Management LLCas of 31 Jan 202435.77k0.11%
Lamashkia Mutual Funds Management Co. (1982) Ltd.as of 31 Dec 202328.68k0.09%
Dimensional Fund Advisors LPas of 28 Mar 202414.78k0.04%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.